Status:

ENROLLING_BY_INVITATION

Deep Versus Standard Prolonged Intermittent Theta Burst Stimulation for Depression

Lead Sponsor:

National Taiwan University Hospital

Conditions:

Intermittent Theta Burst Stimulation

Repetitive Transcranial Magnetic Stimulation

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

This study compares two types of non-invasive brain stimulation to treat major depression in patients who have not found relief from at least one antidepressant medication. The study will use a speci...

Detailed Description

Background: Major depressive disorder (MDD) is associated with dysfunction in large-scale brain networks, including the central executive network (CEN), default mode network (DMN), and the salience n...

Eligibility Criteria

Inclusion

  • Ages between 18 and 70 years, inclusive.
  • Diagnosis of Major Depressive Disorder (MDD) with a current major depressive episode, according to DSM-5 criteria, as confirmed by a psychiatrist.
  • History of inadequate response to at least one trial of an antidepressant medication of adequate dose and duration.
  • A score of 18 or greater on the 17-item Hamilton Depression Rating Scale (HAM-D17) at the screening visit.

Exclusion

  • Lifetime diagnosis of any primary psychotic disorder (e.g., schizophrenia spectrum disorders) or bipolar and related disorders according to DSM-5.
  • Significant current suicide risk, as indicated by a score of 4 on item 3 of the HAM-D17.
  • Current substance use disorder (excluding tobacco) within the last 3 months, according to DSM-5.
  • Presence of significant cognitive impairment, such as intellectual disability, delirium, or a diagnosed neurocognitive disorder.
  • Any personal history of seizures, stroke, brain tumor, brain aneurysm, increased intracranial pressure, or other major neurological disorders.
  • Presence of metal implants in the head (excluding dental fillings) or any implanted medical devices such as a cardiac pacemaker or defibrillator.
  • Currently pregnant.
  • Any other major medical condition that, in the investigator's judgment, could compromise participant safety or interfere with the study procedures.

Key Trial Info

Start Date :

November 24 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2027

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT07198438

Start Date

November 24 2025

End Date

June 30 2027

Last Update

December 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Psychiatry, National Taiwan University Hospital, Yunlin Branch

Douliu, Yunlin County, Taiwan, 640